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Abstract   
Introduction: Biocompatibility is a desirable feature for root-end filling materials. In this 
study we aimed to compare a new material called cold ceramic (CC) with intermediate 
restorative material (IRM) and mineral trioxide aggregate (MTA) using Methyl-tetrazolium 
bromide (MTT) assay. 
Materials and Methods: The materials were tested in fresh and set states: (n=108). The 
cytotoxicity was compared using L929 fibroblasts as an indicator; tested materials were eluted 
with culture medium according to ISO: 109935 standard. Distilled water and culture medium 
served as positive and negative controls, respectively (n=36). The results were evaluated at 1, 24 
hours and 7 days. Data were statistically analyzed by one-way ANOVA for each time interval 
and material status and t-tests. 
Results: The cytotoxicity of the tested materials were statistically different at the various 
time intervals (P<0.001). IRM was the most cytotoxic root-end filling material (P<0.001), MTA 
demonstrated the least cytotoxicity followed by CC.  
Conclusion: Despite displaying the greatest cytotoxicity, IRM is approved by the American 
Food and Drug Administration (FDA). Cold ceramic had significantly lower cytotoxicity 
compared to IRM, in all but one subgroup. Further investigations are required to assess the 
clinical applicability of this novel material. [Iranian Endodontic Journal 2009;4(3):106-11] 
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Introduction 
Though extraction and implant placements 
have become more popular with success rates 
of 98.4% after 15-57 months; research has also 
shown excellent success rates (99.3% after 18-
59 months) for root canal therapy (1) and 
surgical endodontics (91.5% after 5-7 years) 
(2).  
Surgical endodontics is often performed as a 
last resort, after considering or carrying out 
root canal therapy (RCT) or re-RCT (3). There 
are many reasons why apical surgery is 
adopted, for example complex and difficult 
root canal system, strategic or esthetic 
prosthesis, iatrogenic operative blockages or 
overfills (4). Root-end filling material should 
have particular characteristics which have been 
well documented i.e. insolubility, biocom-
patibility and cementogenesis, sealing ability, 
dimensional stability, moisture imperviousness, 
radiopacity and ease of handling (5).  
The close proximity of periodontal tissues to 
the root apex and their extensive blood supply 
make  biocompatibility  very  desirable  feature 





IEJ -Volume 4, Number 3, Summer 2009 
Cold Ceramic’s cytotoxicity 
 
for root-end filling materials (3,5,6). 
MTA is a material that can induce 
cementogenesis (7) due to its high 
biocompatibility and sealing ability (8).  
MTA has been extensively researched and 
compared to IRM in-vitro (5,9) and in-vivo 
(10). 
A clinical trial by Chong et al. demonstrated 
that after 12 and 24 months, MTA had greater 
success rates than IRM, though statistical 
significant difference was not found. MTA 
biocompatibility has been extensively assessed 
by SEM and enzyme assays (11).  
An investigation which had been carried out on 
primary and established cell lines focused on 
the effect of two types of MTA for perforation 
repair as well as GP, amalgam, GICs and super 
EBA; this study found that ProRoot MTA and 
Angelus MTA were superior nontoxic agents 
(12).  
Cytotoxicity has also been investigated for 
MTA on human PDL cells (13); white and grey 
MTA on human osteoblasts (14) and ProRoot 
MTA on human fibroblast PDL cells (15); most 
of the articles concluded that MTA has the least 
cytotoxicity (13-16).  
MTA has various uses such as pulpotomy of 
primary and permanent teeth (17) as well as 
pulp capping, perforation repair and root-end 
restorations (18,19).  
A possible low cytotoxicity of CC will also 
suggest whether CC may also have similar uses 
(20).  
In vitro and ex vivo tests are essentially a form 
of screening (21); materials that demonstrate 
high cytotoxicity can be precluded from more 
expensive and complex in vivo investigations 
(10,22). The regeneration of periodontal and 
periradicular tissues around the root-end 
restorations would be the ideal biological 
response (9,19).  
L929 Fibroblasts are the most commonly used 
standardized established cell line for assessing 
cytotoxicity as the results are more likely to be 
reproducible (13,23). International Standards 
Organization (ISO) has recommended 
preliminary cytotoxic screening (ISO 7405) 
with these cells (13,37).  
We aimed to assess the cytotoxicity of Cold 
Ceramic compared to established materials 
IRM and MTA. 
Materials and Methods  
The study protocol was approved by Shahid 
Beheshti University, Tehran, Ethical 
Committee. 
Study design 
This ex vivo study was designed to evaluate the 
cytotoxicity of three root-end filling materials 
on L929 mouse fibroblasts with MTT assay and 
Elisa reader. The groups were divided as 
follows: Group 1 consisted of IRM fresh and 
set, Group 2 consisted of MTA fresh and set, 
and Group 3 CC fresh and set. Each group was 
assessed at a) 1 hour (subgroup A, b) 24 hours 
(subgroup B), c) 7 days (subgroup C). Each 
group consisted of 36 samples and each 
subgroup of 12 samples each (total of 108). A 
further 36 samples were put aside for positive 
and negative controls (n=18). Distilled water 
and complete DMEM were used as the positive 
and negative controls, respectively, instead of 
extraction vehicle.  
All samples were placed in incubator set at 
37°C, 98% humidity and 5% CO2, and removed 
at the appropriate times (i.e. 1 hour, 24 hours or 
7 days). Note that for the 7 day time span the 
extraction vehicles were replenished every 48 
hours to sustain cell viability.  
The L929 mouse fibroblasts (Pastor Institute, 
Tehran, Iran) were taken from solid form and 
de-solidified and washed out in tryspin (USA 
and GIBCO) 4 times.   
Specimens with a vitality rate of over 95% 
were utilized for the investigation. The cells 
were then placed on a slide and counted with 
hemocytometer. A monolayer of cells totaling 
6,000 was placed inside each well (plates 
contained 96 wells each) (Cellstar, Greinerbio-
one). Three plates were used for materials, for 
each of the time intervals. The negative and 
positive controls also had 3 plates each. The 
culture mediums were placed in Dulbeccos’ 
modified Eagle’s medium, (DMED), (Life 
Technologies Inc Grand) fortified with 10% 
Fetal Bovine Serum (FBS) as well as penicillin 
antibiotic 100 IU/mL (Sigma USA) and 
streptomycin 100 µg/mL (Sigma, USA). The 
samples were kept at 37oC, 98% humidity and 
5% carbon dioxide. 
Root-end filling materials were prepared 
according to manufacturer’s and inventor’s 
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environment with a sterile instrument. Fresh 
subgroups were immediately placed in 3 mm 
thicknesses inside wells. The set subgroups 
were prepared in 3 mm thicknesses and then 
placed in 98% humidity and 37oC under UV 
light for 24 hours. The extraction vehicle in our 
study contained complete DMED with normal 
saline (pH balanced) and the root-end filling 
material. After 10 minutes of preparing the 
subgroups, the 4 mL of culture mediums were 
added to experiment and control wells. 
Afterwards, the extractions were filtered with 
0.22 µm syringe (Schjeicher and Schwell) to 
ensure sterile conditions were met.  
For carrying out MTT assay, 5mg/mL methyl 
tetrazolium bromide salts (Sigma-Aldrich, 
USA) in phosphate buffer solution (PBS) were 
mixed with DMEM (ratio of 1:10). The 
extraction was first evacuated and 150 µL of 
this solution was added to each well. The 
material was then incubated for four hours in 
identical conditions (i.e. 37oC, 98% humidity 
and 5% CO2).   
The top layer of the solutions was removed and 
instead 150 µL of isopropananolic acid was 
added to each well. Next 100 µL was taken 
from each well and placed in the Elisa reader 
(Anthos 2020, Australia) microplates. Optical 
density had initially been collaborated with the 
negative control value to obtain an accurate 
comparison. Optical density was then assessed 
under a wavelength of 570 nm and a filter 
reference of 620 nm. 
Two-way ANOVA test were performed. 
Independent t test and Tukey test were also 
used for pair comparison. Statistical 
significance was established at P<0.05.  
 
Results  
Table 1 indicates that the cell viability of Cold 
Ceramic equaled MTA and negative control in 
both set and fresh states after one hour. IRM 
demonstrated the lowest cell viability, 
significantly less than CC and MTA in both 
states. Set IRM had no cell viability (i.e. 
equalling positive control). After 24 hours, 
MTA had statistically greater cell viability than 
CC in both states (P<0.001); and CC 
demonstrated superior cell viability to IRM and 
positive control in both states (P<0.001). In 
subgroup C (7 days), fresh and set states 
demonstrated significantly different results 
(Table 1 and 2). Fresh CC demonstrated similar 
cytotoxicity to fresh IRM and positive control. 
The cell viability values for set CC, on the 
other hand, was greater than set IRM  and 
equalled set MTA. We can conclude that 
negative control>(set MTA=set CC) and (set 
MTA=set CC)>(set IRM=positive control) and 
also, that negative control>fresh MTA> (fresh 
CC=fresh MTA=positive control). 
The lowest recorded cytotoxicity was expressed 
by MTA in 5 of its subgroups, but only in one 
of CC subgroups (Table 2). 
 
Discussion 
In this study set and fresh material were 
analyzed to determine whether cytotoxicity 
resulted from setting process or the by the by-
products the set material released. Most studies 
do not analyze materials after 7 days (21,24) as 
maintaining vitality for long durations requires 
extra care; in this study the extract medium was 
changed every 48 hours (25).  
MTT is a simple and popular in vitro test but 
with certain limitations (26,27). The ex vivo 
environment does not replicate the biological 
response of the periapical tissues; in vivo tests 
would therefore be advisable if positive results 
were obtained from ex vivo tests.  
MTA is steadily becoming the gold standard 
material in endodontics with which many new 
materials are compared (5,28).  
In this study, only three subgroups of MTA 
demonstrated superior cell viability to CC: set 
and fresh MTA in subgroup B (24 hours) and 
fresh MTA in subgroup C (7 days). In all other 
subgroups CC and MTA had similar cell 
viability values suggesting that CC may be a 
viable option as a relatively biocompatible root 
end filling material. Cold Ceramic’s sealability 
has been compared with MTA introduced as a 
suitable alternative to MTA, in terms of 
sealability (29,30). In this study CC 
demonstrated competitive cell viability values 
when set; moreover, CC was consistently 
second or equal to MTA. A material that has 
repeatedly demonstrated low cytotoxicity 
(31,5). The biocompatibility of MTA has been 
commonly associated with their ability to 
release calcium ions as they set and the 
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Table 1. Comparison of Cell viability values after 1, 24 hours and 7 days (subgroups A, B and C) among 
tested materials 









fresh IRM freshCC>freshIRM* __ freshIRM>control* freshIRM>neg^^control*  
set IRM setCC>setIRM** __ setIRM=control setIRM> neg control**  
fresh MTA# freshMTA=freshCC freshMTA>freshIRM* freshMTA>control* freshMTA=neg control  
set MTA setMTA=setCC setMTA>setIRM** setMTA>control* setMTA=neg control  
fresh CC __ See above setCC>control* freshCC=neg control  













fresh IRM freshCC>freshIRM* __ freshIRM=control freshIRM>neg^^control*  
set IRM setCC>setIRM* __ setIRM=control setIRM> neg control*  
fresh MTA* freshMTA>freshCC* freshMTA>freshIRM* freshMTA>control* freshMTA>neg control*  
set MTA setMTA>setCC* setMTA>setIRM* setMTA>control* setMTA=neg control  
fresh CC __ __ freshCC>control** freshCC>neg control*  








) fresh IRM freshCC=freshIRM __ freshIRM=control freshIRM>neg^^control*  
set IRM setCC>setIRM* __ setIRM=control setIRM> neg control*  
fresh MTA* freshMTA>freshCC** freshMTA>freshIRM* freshMTA>control* freshMTA>neg control*  
set MTA setMTA=setCC setMTA>setIRM* setMTA>control* setMTA>neg control*  
fresh CC __ __ freshCC=control  freshCC>neg control*  
set CC __ __ setCC>control* setCC>neg control*  
*Statistically significant by two-way ANOVA tests and confirmed by Tukey test (P<0.001) 
** Statistically significant by two-way ANOVA tests and confirmed by Tukey test (P<0.05) †Cold ceramic, ‡Intermediate 
Restorative Material, # Mineral Trioxide Aggregate, ^^negative control  
 
Table 2. Mean (SD) values for three subgroups 









f ** IRM 0.49 (0.13) 0.09 (0.07) 0.00 (0.02) 
s≠ IRM  0.40 (0.20) 0.20 (0.07) 0.00 (0.02) 
f MTA  1.03 (0.12) 0.73 (0.11) 0.47 (0.11) 
sMTA  0.93 (0.12) 0.99 (0.10) 0.60 (0.22) 
fCC 0.94 (0.24) 0.21 (0.073) 0.02(0.008) 
sCC 0.99 (0.32) 0.50 (0.01) 0.41 (0.08) 
* Cell viability values according to Elisa Reader, **Fresh, ≠Set 
 
hydroxyapatite crystals, facilitating healing 
(32). Camilleri et al. showed that fresh MTA 
has greater biocompatibility than its set state 
(33); the fresh form better emulates the clinical 
usage of this material in retrograde fillings. Our 
results however, show that there are no 
differences between set and fresh states except 
after 7 days (subgroup C) where set state is 
superior. In group C, fresh CC had significantly 
poorer cell viability compared to its set state; 
the fresh state statistically equaled IRM values 
and set state equaled set MTA (P>0.05) (Tables 
1 and 2). 
Ghoddusi et al. examined the cytotoxicity of 
MTA and a new endodontic cement using MTT 
assay and found greater cytotoxicity in the 
fresh form as well as significant difference 
among some of their time intervals (24, 48 and 
72 hours), concurring with our findings (24). 
The presence of calcium hydroxide produced as 
a by-product of the hydration reaction of MTA 
has been demonstrated (11) whether CC has 
similar by products is as yet to be determined. 
The cell viability decrease could be the result 
of the cell death caused by hydroxyl ion release 
(high pH) of MTA and possible CC. Freshly 
mixed MTA causes denaturation of adjacent 
cells and medium proteins with a surrounding 
zone of lysed cells. Normal cells can be seen 
beyond the lyses zone. As the MTA sets, the 
pH changes and the cell injuries subside 
(34,35). Notably, studies performed on GICs 
biocompatibility have been inconclusive. This 
may be due to the little importance given to the 
chemical reactions of the material during and 
after setting (36).  
This new prototype material though based on 
tricalcium silicate; contained admixtures that 
interfered with the production of calcium 
hydroxide. Since calcium ion and calcium 
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suppressed, the carbonation was less marked. 
The biocompatibility of the prototype and its 
variants was similar to that of an established 
glass-ionomer material (36,44). Cold ceramic 
however, does not have this disadvantage. 
In this study, MTA and CC demonstrated 
significantly greater cytotoxicity at 7 days 
compared to one hour (Table 2), possibly due 
to the gradual release of hydroxyl ion (high 
alkalinity) over time, which may be neutralized 
in contact with body tissue fluid but not in ex 
vivo condition. However in set state CC 
equaled MTA, demonstrating its potential as a 
root-end filling material in terms of low 
cytotoxicity.  
IRM, though an FDA approved material, had 
significantly greater cytotoxicity than MTA, a 
well known biocompatible material (31) as well 
as CC in almost all subgroups of this study.  
A clinical trial demonstrated differences in 
success rates between IRM and MTA as root-
end filling materials (37), supporting previous 
research (10). However, statistical difference 
was not established. 
 
Conclusion  
Further in vivo and ex vivo studies are required 
to assess the properties and clinical use of Cold 
Ceramic. Our study demonstrated that CC is a 
competitive material with low cytotoxicity. 
Cold ceramic may be clinically relevant root-
end filling material; having superior cell 
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